208 related articles for article (PubMed ID: 30584005)
1. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance.
Chien SC; Chen PS; Huang YH; Tang SC; Li YH; Yeh HI
J Formos Med Assoc; 2019 Oct; 118(10):1385-1392. PubMed ID: 30584005
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
3. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
4. Statin intolerance - a question of definition.
Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
[TBL] [Abstract][Full Text] [Related]
5. Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects.
Li JJ; Liu HH; Wu NQ; Yeo KK; Tan K; Ako J; Krittayaphong R; Tan RS; Aylward PE; Baek SH; Dalal J; Fong AYY; Li YH; O'Brien RC; Lim TSE; Koh SYN; Scherer DJ; Tada H; Kang V; Butters J; Nicholls SJ
Expert Opin Drug Metab Toxicol; 2020 Sep; 16(9):837-851. PubMed ID: 32729743
[TBL] [Abstract][Full Text] [Related]
6. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
Stock J
Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
[No Abstract] [Full Text] [Related]
7. Statin Intolerance: A Review and Update.
Tsushima Y; Hatipoglu B
Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Statin Intolerance.
Alonso R; Cuevas A; Cafferata A
J Atheroscler Thromb; 2019 Mar; 26(3):207-215. PubMed ID: 30662020
[TBL] [Abstract][Full Text] [Related]
9. Expert opinion: the therapeutic challenges faced by statin intolerance.
Patel J; Martin SS; Banach M
Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
[TBL] [Abstract][Full Text] [Related]
10. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
11. Muscle and statins: from toxicity to the nocebo effect.
Pedro-Botet J; Climent E; Benaiges D
Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
[TBL] [Abstract][Full Text] [Related]
12. Management of statin-intolerant patient.
Arca M; Pigna G; Favoccia C
Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
[TBL] [Abstract][Full Text] [Related]
13. Non-traditional dosing of statins in statin-intolerant patients-is it worth a try?
Cornier MA; Eckel RH
Curr Atheroscler Rep; 2015; 17(2):475. PubMed ID: 25432858
[TBL] [Abstract][Full Text] [Related]
14. Optimizing Cholesterol Treatment in Patients With Muscle Complaints.
Rosenson RS; Baker S; Banach M; Borow KM; Braun LT; Bruckert E; Brunham LR; Catapano AL; Elam MB; Mancini GBJ; Moriarty PM; Morris PB; Muntner P; Ray KK; Stroes ES; Taylor BA; Taylor VH; Watts GF; Thompson PD
J Am Coll Cardiol; 2017 Sep; 70(10):1290-1301. PubMed ID: 28859793
[TBL] [Abstract][Full Text] [Related]
15. [Statin intolerance and associated muscular dysfunctions].
Boulanger-Piette A; Bergeron J; Desgreniers J; Côté-Levesque M; Brassard D; Joanisse DR; Frenette J
Med Sci (Paris); 2015 Dec; 31(12):1109-14. PubMed ID: 26672664
[TBL] [Abstract][Full Text] [Related]
16. [Statin-induced adverse effects -- facts and genes].
Harangi M; Zsíros N; Juhász L; Paragh G
Orv Hetil; 2013 Jan; 154(3):83-92. PubMed ID: 23315223
[TBL] [Abstract][Full Text] [Related]
17. Statin myopathy: over-rated and under-treated?
Maghsoodi N; Wierzbicki AS
Curr Opin Cardiol; 2016 Jul; 31(4):417-25. PubMed ID: 27258372
[TBL] [Abstract][Full Text] [Related]
18. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).
Mancini GB; Baker S; Bergeron J; Fitchett D; Frohlich J; Genest J; Gupta M; Hegele RA; Ng D; Pearson GJ; Pope J; Tashakkor AY
Can J Cardiol; 2016 Jul; 32(7 Suppl):S35-65. PubMed ID: 27342697
[TBL] [Abstract][Full Text] [Related]
20. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association.
Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK;
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
